PB 3 of 2022
National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2022 (No. 1)
I, NIKOLAI TSYGANOV, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, and delegate of the Minister for Health and Aged Care, make the following determination.
Dated 27 January 2022
NIKOLAI TSYGANOV
Assistant Secretary (Acting)
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health
Contents
1 Name…………………………………………………………………………….………………1
2 Commencement
3 Authority
4 Schedule
Schedule 1—Amendments 2
National Health (Continued Dispensing - Emergency Measures) Determination 2020 2
1 Name
(1) This instrument is the National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2022 (No. 1).
(2) This instrument may also be cited as PB 3 of 2022.
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information |
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 1 February 2022 | 1 February 2022 |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under subsection 89A(3) of the National Health Act 1953.
4 Schedules
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1—Amendments
National Health (Continued Dispensing – Emergency Measures) Determination 2020
[1] Schedule 1, entry for Adrenaline (epinephrine)
omit:
| Solution for injection 1 mg (as tartrate) in 1 mL (1 in 1,000) | Injection |
[2] Schedule 1, after entry for Levothyroxine in the form Tablet containing 100 micrograms anhydrous levothyroxine sodium
insert:
| Tablet containing 125 micrograms anhydrous levothyroxine sodium | Oral |
[3] Schedule 1, entry for Ribavirin
omit:
| Tablet 400 mg | Oral |
| Tablet 600 mg | Oral |
[4] Schedule 1, after entry for Upadacitinib in the form Tablet 15 mg
insert: